• Guest - w'd love to know what you think about the forum! Take the 2026 Survey »

Search Results

  1. B

    Latest research into Terzepatide (Mounjaro) for T1 in USA

    Life-changing medications like Ozempic and Mounjaro are only approved right now for type 2 diabetes, but a growing body of evidence highlights the benefits of GLP-1s for people with type 1 diabetes. Now, researchers are analyzing the data to see how GLP-1 drugs affect the risk of heart, kidney...
  2. B

    Insulin and self medication in hospital

    https://www.hssib.org.uk/patient-safety-investigations/insulin-supporting-safe-administration-in-inpatient-settings/investigation-report/#executive-summary Investigation report Insulin: supporting safe administration in inpatient settings
  3. B

    Weight loss/gain after stopping GLP-1

    https://newsroom.clevelandclinic.org/2026/03/12/what-happens-when-patients-stop-taking-glp-1-drugs-new-cleveland-clinic-study-reveals-real-world-insights What Happens When Patients Stop Taking GLP-1 Drugs? New Cleveland Clinic Study Reveals Real World Insights
  4. B

    T2D comparison of Mounjaro with Semaglutide

    https://dom-pubs.pericles-prod.literatumonline.com/doi/full/10.1111/dom.16508 Indirect comparative efficacy and safety of tirzepatide 10 and 15 mg versus semaglutide 2.4 mg for the management of obesity and overweight in patients with type 2 diabetes
  5. B

    T1D GLP-1 comparison

    Mounjaro gives greater weight loss and other improvements. https://dom-pubs.pericles-prod.literatumonline.com/doi/full/10.1111/dom.70172 Weight loss in people with type 1 diabetes over 12 months: Real-world data comparing tirzepatide, semaglutide and liraglutide
  6. B

    GPs to be rewarded for maximising Mounjaro use

    It will be interesting to follow changes in prescribing - it is possible to see individual surgeries in https://openprescribing.net/analyse/#org=practice&orgIds=00L&numIds=0601023AZBB,0601023ABBC&denom=total_list_size&selectedTab=summary I have used Northumberland as an example but any area...
  7. B

    New guidance for T2D from NICE

    https://www.nice.org.uk/guidance/ng28
  8. B

    Could your wifi router be used in the future to monitor for night time hypos

    Without ANY direct connection to your body Medscape: How Wi-Fi Could Become an Invisible, No-Touch ECG Wi-Fi signals bounce off humans in predictable patterns and can detect respiration and pulse, creating an invisible, whole-room health monitor that never touches the patient. Wi-Fi signals...
  9. B

    Libre 3 Warning

    https://abbott.mediaroom.com/press-releases?item=124718 3 Million in the USA but far higher numbers have severe effect elsewhere than in the US. “Globally, Abbott has received reports of 736 severe adverse events (57 in the U.S.) and seven deaths (none in the U.S.) potentially associated with...
  10. B

    Regional disparity

    It is interesting to see that some areas do place greater weight on NHS prescription of Mounjaro.
  11. B

    Inpatient treatment

    Now the pharmacists have become involved https://pharmaceutical-journal.com/article/news/pharmacists-cut-medication-errors-and-costs-on-diabetes-and-endocrinology-wards-study-results-show
  12. B

    Why compare BGM and CGM Values?

    Surely what really matters is the Medical Results - not the readings from either A large Swedish study demonstrates this - This is the comparison that really matters - The values from each device type is immaterial- what is important is the results to Health These are not small differences ….
  13. B

    Diabetes user groups on Facebook being shut down

    A number of Facebook peer support groups have been suddenly shut down by Facebook both in the U.K. and elsewhere. Some of these have tens of thousands of active members and have been running for a number of years. The reason given is copyright infringement of the name “Freestyle Libre”. A...
  14. B

    CPR instructions

    Does anyone check read your posts? CPR two times every MINUTE?
  15. B

    Libre and COVID

    Abbott have just filed their quarterly accounts. A MASSIVE 62% increase in sales. ”Growth in Diabetes Care sales was driven by continued growth of FreeStyle Libre ® , Abbott’s continuous glucose monitoring system, internationally and in the U.S. FreeStyle Libre sales totaled $604 million in the...
  16. B

    COVID 2019 Comorbidity with Diabetes

    Very little has been said about the particular risks of Coronavirus to PWD. We often read that the risk of death with Coronavirus is "only" 2%, with critical illness about 10% But then we read that most of those suffering serious effects have pre-existing conditions. 80% have a pre-existing...
Back
Top